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Abstract—This paper presents the architecture and initial us-
ability results of an advanced insulin bolus calculator for diabetes
(ABC4D), which provides personalised insulin recommendations
for people with diabetes by differentiating between various
diabetes scenarios and automatically adjusting its parameters
over time. The proposed platform comprises two main compo-
nents: a smartphone-based patient platform allowing manual
input of glucose and variables affecting blood glucose levels
(e.g. meal carbohydrate content, exercise) and providing real-
time insulin bolus recommendations; and a clinical revision
platform to supervise the automatic adaptations of the bolus
calculator parameters. The system implements a previously in-
silico validated bolus calculator algorithm based on Case-Based
Reasoning (CBR), which uses information from similar past
events (i.e. cases) to suggest improved personalised insulin bolus
recommendations and automatically learns from new events.
Usability of ABC4D was assessed by analysing the system usage
at the end of a six-week pilot study (n=10). Further feedback on
the use of ABC4D has been obtained from each participant at
the end of the study from a usability questionnaire. On average,
each participant requested 115 ± 21 insulin recommendations,
of which 103 ± 28 (90%) were accepted. The clinical revision
software proposed a total of 754 case revisions, where 723 (96%)
adaptations were approved by a clinical expert and updated in
the patient platform.
Index Terms—Diabetes Mellitus, Insulin Bolus Calculator,
Decision Support Systems, Case-Based Reasoning.
I. INTRODUCTION
AT present, the majority of people with Type 1 diabetesmellitus (T1DM) control their blood glucose levels by
drawing blood from the fingertips and measuring glucose
concentration with a blood glucose meter (i.e. self-monitoring
of blood glucose) [1], and by administering insulin through
multiple daily injections or continuous subcutaneous insulin
infusion pumps. Insulin boluses are usually calculated by esti-
mating the insulin required to cover the ingested carbohydrates
and by adding the insulin needed to correct elevated pre-
meal glucose levels to target (i.e. correction bolus). Existing
technologies used in diabetes management, such as insulin
pumps and some blood glucose meters, incorporate bolus
calculators [2] that help users to simplify these calculations
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and potentially improve glycaemic control [3]–[6]. A standard
insulin bolus calculator can be described as follows:
B =
CHO
ICR
+
G−GT
ISF
− IOB, (1)
where B is the calculated bolus; CHO the amount of estimated
carbohydrates consumed; ICR is the insulin-carbohydrate
ratio which describes the grams of ingested carbohydrates that
are covered per one unit of insulin;G the current blood glucose
measurement; GT is a predefined glucose target and ISF
the insulin sensitivity factor which describes the reduction in
blood glucose concentration per one unit of insulin. Bolus
calculators also consider the remaining active insulin from
previous boluses, commonly referred to as insulin-on-board
(IOB). The tuning of bolus calculator parameters depends
on various factors such as: the time of the day, physical
activity level, hormonal cycles, psychological stress, alcohol
and illness. Therefore, it is important to adapt parameters
to these situations and re-adjust them over time. Different
algorithms have been proposed to automatically adapt bolus
calculator parameters [7]–[9]. However, to our knowledge,
none of them have been commercially adopted for use in
diabetes management [10]. One of the main hurdles for
adoption and utilisation is down to usability and acceptability
of the systems for both patients and clinicians [2]. In this
paper, we present the architecture of an advanced insulin bolus
calculator that tackles the aforementioned hurdles that so far
prevented clinical and commercial adoption. The platform has
been designed with feedback from patients and clinicians with
focus on safety and enhanced usability. Finally, we present
results of a pilot study assessing the usability and acceptability
of the proposed platform.
II. MATERIALS AND METHODS
A. An Advanced Bolus Calculator for Diabetes (ABC4D)
The proposed bolus advisory system implements an in silico
validated advanced insulin bolus calculator [11] based on
Case-Based Reasoning (CBR) [12], [13], which provides per-
sonalised insulin recommendations and automatically adapts
its parameters over time. CBR is an artificial intelligence
technique that solves newly encountered problems by applying
the solutions learned from solving similar problems encoun-
tered in the past (i.e. cases). In CBR, a case is defined by
three components: the problem description, the solution to the
problem and the outcome [13]. The problem is described by
a set of parameters that could potentially affect glucose levels
(e.g. meal, exercise, time of the day), the solution is defined
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Fig. 1. Manual and automatic case parameters used to generate an insulin advice on the patient platform (left). All used cases are periodically (e.g once a
week) sent to the clinical platform (right) for revision. After all case adaptations have been approved by a clinical expert, the updated case base is sent back
to the patient platform via encrypted email.
by the parameters of a bolus calculator (i.e. ICR and ISF) and
the outcome is a glycaemic metric assessing the postprandial
glucose excursion which can be evaluated using continuous
glucose monitoring (CGM) data.
Adapting Insulin Therapy with Case-Based Reasoning: The
CBR algorithm can be described in four steps [13]:
• Retrieve cases from the case base and select the one
that is most similar to the current situation (i.e. meal
scenario) using a selected similarity metric (e.g. k-nearest
neighbours).
• Reuse the solution of a successfully retrieved case. If
necessary, the solution can be further adjusted to the
current scenario.
• Revise the glycaemic outcome (e.g. postprandial hypo-
glycaemia or glucose area under curve) of the applied
solution, if the user accepted the bolus advice. In case
the outcome is unsatisfactory, adaptation of the solution
of the retrieved case may be required [9].
• Retain the adapted case in the case base or create a new
case describing the current meal scenario if no similar
case has been found.
B. System Architecture of the Patient and Clinical Platform
The proposed ABC4D system comprises a patient platform
consisting of a smartphone application and a computer-based
clinical platform (Figure 1). The patient platform allows
manual user input of relevant glucose-related data and provides
real-time bolus advice. The clinical platform aims to guarantee
patient’s safety by allowing the clinician to easily analyse and
accept changes to the insulin therapy proposed by the CBR
algorithm. In order to warranty patient safety, the proposed
platform separates the CBR cycle into two parts. The first part,
comprising the retrieval and adaptation steps, is integrated into
the patient advisory platform; while the second part, containing
the revision and the retention steps, is performed within the
clinical platform (see Figure 2). The functional separation of
the CBR cycle ensures that only clinically safe adaptations are
performed.
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Fig. 2. Implemented CBR cycle proposed by Aamadt and Plaza [13], split
into a patient and clinical platform.
For practicality reasons, case revisions can be performed
periodically by a clinical expert (e.g. weekly). Periodic revi-
sion also has the advantage to filter out potential outliers if a
case has been used more than once.
Figure 3 shows the software system architecture of both
the patient advisory and clinical supervision platforms. The
main difference in the structure of the architecture between
the two platforms lies in the algorithm layer. The algorithm
layer of the patient platform contains the bolus calculator
formula as described in Equation 1, as well as CBRs retrieval
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Fig. 3. Software architecture and user interaction of the ABC4D patient smartphone platform (left) and clinical revision platform (right).
and reuse steps, while the same layer of the clinical platform
implements the revision and retention steps of the CBR cycle.
ABC4D Patient Smartphone Platform: The system archi-
tecture of the patient platform is structured as follows:
1) The presentation layer holds the logic for the graphical
user interface, which is responsible for retrieving manual
input parameters and presenting requested bolus recom-
mendations to the patient.
2) The algorithm layer contains the retrieval and reuse steps
of the CBR cycle and the bolus calculator formula.
Whenever the user requests a new bolus advice, the
retrieval algorithm compares the current scenario with
existing cases in the case-base and returns the solu-
tion (i.e. bolus calculator parameters) and, if necessary,
adapts the retrieved solution to the current scenario
(reuse step). The bolus calculator formula uses this solu-
tion to calculate the recommended insulin dose, which
is sent to the presentation layer to display the advice,
through the graphical user interface, to the patient.
3) The safety layer implements risk mitigation and risk
control measures to ensure maximum safety of the sys-
tem. Risk mitigation is implemented to ensure that only
safe (i.e. physiological) values are entered via the user
interface as well as to verify each parameter retrieved
from the database. Risk control limits the maximum
amount of insulin to be advised which can be pre-defined
for each user by the clinical expert.
4) The data layer is responsible for storage, maintenance,
security of data stored in the local databases as
well as providing secure transmission to the clinical
platform. The data layer contains three databases: 1)
An event-database which contains log book entries and
information about all glucose related user entries and
insulin requests; 2) a case database (i.e. case base)
containing all generated cases and information about
their usage and 3) a settings-database to store security
information, patient details and personal settings. The
data layer also manages access to automatic input
parameters (e.g. exercise information through external
accelerometer.)
ABC4D Clinical Revision Platform:
1) The presentation layer is responsible for the graphical
user interface of the revision platform. It allows the
clinician to import the log book and cases retrieved from
the patient platform as well as additional data (e.g. CGM
data) required by the revision algorithm. During the revi-
sion process, the user interface displays glucose graphs,
meal information, selected parameters (e.g. exercise) and
retrieved cases used for each scenario where an insulin
advice has been requested. A suggested adaptation to
the solution of the retrieved case is presented to the
clinical expert who needs to approve or decline each
case adaptation.
2) The algorithm layer holds the revision and reuse steps
of the CBR algorithm. The revision algorithm calculates
adaptations to the solution of each case that has been
used. After all case adaptations have been revised, the
approved cases are updated into the case base of the
patient platform (retain step).
3) The safety layer of the clinical revision platform ensures
that all essential data have been imported and checks the
databases for validity. In order to avoid overly aggres-
sive adaptations, safety constraints limit the maximum
allowed change to a case solution by a pre-defined
percentage.
4) The data layer is responsible to synchronise and store
data that has been uploaded from the patient platform. It
contains a duplicate of all databases from the phone in
addition to usage information and historical data from
previous case adaptations.
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Fig. 4. Main screen of ABC4D patient platform to enter manual input
parameters and request an insulin advice (left) and display of an insulin bolus
recommendation with the option of accepting or declining the advice, or to
request more information on how the advice has been generated (right).
C. Implementation
CBR Algorithm: Several algorithms exist for case retrieval
[14] and adaptation of bolus calculator parameters (i.e. case
solution) [7], [8] which can be integrated in the proposed plat-
form. The CBR cycle implemented in the proposed ABC4D
system is based on [11]. Following case parameters are used
by ABC4D: Range of glucose level, time-of-day, exercise,
alcohol and absorption rate. All parameters were weighted
equally (i.e. weight = 1) for case retrieval. Parameter time-
of-day was used to differentiate cases within the case-base
between breakfast, lunch and dinner, which is used to account
for potential changes in insulin sensitivity during the day.
Therefore, a case retrieved in the morning will only be
compared to ’breakfast’ cases; a lunch scenario only compared
with cases using parameter lunch, and so on. The time is
automatically retrieved from the system time of the phone
when requesting an advice. Glucose data from a CGM is
used for case revision to assess the outcome of a suggested
insulin bolus by evaluating the minimum postprandial glucose
value within a pre-defined time window. The length of the
time window (e.g. 4 hours) is depended on the insulin-action-
time of the individual user and can be defined a priori by the
clinical expert. For more details about the adaptation metric,
the reader is referred to [9].
Patient Smartphone Platform: The ABC4D patient platform
is built on the presented architecture and has been imple-
mented in an off-the-shelf smartphone (Hardware: iPhone
4S, Apple Inc. California; Programming Environment: X-
Code/Objective-C; Database: SQLite3). Special attention was
put on designing the graphical interface to make it as user-
friendly as possible. Feedback obtained from a focus group
meeting (i.e. five adults with T1DM and similar demographics
compared to the study group) was used to improve the
usability of the patient platform prior the development of the
software (see section III-A).
Figure 4 (left) shows the main screen of the smartphone
Fig. 5. Clinical revision software reviewing a breakfast scenario with exercise
and proposing an adaptation to the insulin-carbohydrate-ratio (ICR) of a case.
application used for requesting a new recommendation.It con-
tains input elements to enter manual parameters (i.e. amount
of carbohydrates, meal absorption, current blood glucose level,
alcohol consumption and exercise) and a button for requesting
insulin bolus advice. The insulin recommendation is then
presented to the user via a graphical user interface (see Figure
4 (right)). Each recommendation needs to be accepted or
declined manually, while the latter option requires the user
to input the actual insulin dose that has been delivered. Users
could give reasons for declining bolus advice through selecting
one of following check-boxes:
• Too much insulin
• Too little insulin
• Other/Manual user comment
Declined recommendations by the user were used for revision.
However, instead of the solution of the retrieved case, the
solution proposed by the user is revised and, if non-optimal
outcome, adapted.
All user input and recommendations are locally stored in a
relational database management system (i.e. SQLite3) on the
phone. This enables the user to have access to past glucose
information and recommendations at all times. Data essential
for case revision can be exported as an Excel (Microsoft) file
and sent encrypted via email to the clinical expert.
Clinical Revision Platform: The clinical revision platform
has been implemented in MATLAB (The MathWorks, Inc) and
is designed to run on a desktop computer. Figure 5 shows a
screenshot of the clinical revision software, displaying the revi-
sion of proposed adaptation for the solution (i.e. ICR and ISF)
of a presented case. In case the user administered additional
insulin or consumed another meal with insulin within 4 hours
after the bolus advice, then this scenario will be excluded for
revision as it is not clear if a potential bad glycaemic outcome
was the result of the initial bolus advice or because of the
user intervention. However, cases solutions are still revised in
scenarios when participants consumed carbohydrates without
administration of insulin to correct for hypoglycaemia. After
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TABLE I
USAGE OF PATIENT PLATFORM DURING A SIX WEEKS PILOT STUDY
No Bolus No Logbook No Accepted No Declined Bolus Advice/Day Logbook-Entries/Day Usage Time (s)
Part Advices Entries Advices Advices Week 1 Week 6 Week 1 Week 6 Week 1 Week 6
1 70 16 66(94.3%) 4(5.7%) 2.4 1.7 0.3 0.9 52±34 33±16
2 135 212 127 (94.1%) 8 (5.9%) 3.7 2.4 6.4 3.0 133±106 63±55*
3 126 214 122 (96.8%) 4 (3.2%) 2.9 3.4 5.6 4.3 39±25 18±23**
4 132 154 132 (100%) 0 (0.0%) 3.1 3.3 5.4 4.3 170±99 140±65
5 97 186 51 (53.6%) 46 (47.4%) 2.7 2.1 5.3 2.3 122±44 96±29*
6 111 60 105 (94.6%) 6 (5.7%) 2.9 2.1 3.1 0.7 98±68 30±18**
7 96 207 76 (79.2%) 20 (20.8%) 2.1 2.4 9.9 5.0 98±89 88±48
8 124 15 114 (91.9%) 10 (8.1%) 2.9 3.1 0.7 0.0 111±63 58±42**
9 126 106 106 (84.1%) 20 (15.9%) 3.0 3.0 2.1 2.0 71±45 33±26**
10 132 44 127 (96.2%) 5 (3.8%) 3.3 3.4 2.6 0.0 102±61 61±37**
Total 1149 1214 1026 123 - - - - - -
Mean±STD 115±21 121±83 103±28(90%) 12±14(10%) 2.9±0.4 2.7±0.6 4.1±2.9 2.3±1.9* 100±63 62±36**
*p <0.05 **p <0.01
the revision of the cases has been completed, the software
shows a summary of all adapted cases to the clinician.
If one case has been used and revised multiple times, an
average of all adaptations is calculated which, in turn, needs
to be manually approved. Finally, the case base on the patient
platform needs to be updated. This can be performed either
on the phone itself through an authorised settings menu or
remotely via email.
D. Evaluation of Patient and Clinical Platform
The usability and acceptability of the patient platform
was evaluated as part of a clinical pilot study. Regulatory
approvals were obtained from the regional ethics commit-
tee (REC 13/LO/0264) and the MHRA. Participants were
recruited from the Imperial College Healthcare NHS Trust.
Inclusion criteria were: diagnosis of T1DM for >1 year, age
>18 year, HbA1c <86 mmol/mol (<10 %) and completed
structured education. Ten adults with T1DM with a mean
(SD) age of 42(17) years, diabetes duration of 21(15) years
and HbA1c = 64(15) mmol/mol (8.1(1.4)%) participated in
the study. Although ABC4D can be equally used by people
using CSII, all participants were on multiple daily injections
(MDI) in order to be consistent when analysing the usability
of the system. Each participant used the patient platform
continuously for six weeks to receive insulin bolus advice
and log additional diabetes events such as snacks, additional
capillary blood glucose measurements and correction boluses
of insulin. A blinded CGM was worn by the participants
for the whole duration of the pilot study. Its glucose data
was uploaded once a week by the research team for case
revision. At the end of the study, all participants were asked to
complete a usability questionnaire. Furthermore, we recorded
the number of times the software had been used and the time
needed to request and review a bolus advice. A clinician,
a clinical research nurse and an engineer used the clinical
platform at the end of each study week to approve case
adaptations for each accepted bolus advice. Safety measures
(e.g. maximum amount of recommended insulin dose) and
initial cases with clinically safe solution, based on subject-
specific insulin:carbohydrate ratios, were set by a clinical
expert at the start of the study and were not accessible to
the user.
III. RESULTS
A. Patient Platform
Implemented changes on the graphical user interface of
the patient platform following feedback from the focus group
meeting prior the study included: Simplification of the main
menu, changing the input methods for entering carbohydrates
and glucose levels (i.e. changing scroll wheel to numeric
keypad) and adding explanatory text that informs the user in
detail on how recommendations have been generated.
Table I shows the ABC4D usage of all subjects (n=10) par-
ticipating in the six-week pilot study. On average, 115±21 in-
sulin recommendations have been requested of which 103±28
(90%) were accepted by the participants. For the majority of
all declined recommendations participants found the proposed
insulin dose was not enough (64%), while for 32% of all
declined advice participants felt the insulin dose was too
much. No reasons were provided by the user for the remaining
4% of declined advice. While participants used the log book
function of the application less in the last week of the study
(p<0.05), no statistically significant change was observed
when analysing the average number of requested bolus recom-
mendations when comparing the initial study week with the
last week. The mean time spent for requesting a bolus advice
using the application (i.e. time from opening the software until
closing it) was 100±63 seconds in the first week. This value
was significantly (p<0.01) reduced to 62±36 seconds in the
last week. Table III shows the outcome of the questionnaire
assessing system usability and acceptability after completion
of the six week study. The majority of people considered
the ABC4D platform as user-friendly, to trust the generated
advice and to be happy to use the platform. However, some
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TABLE II
RESULTS OF CLINICAL REVISION PLATFORM ANALYSING PROPOSED
BOLUS RECOMMENDATIONS
No of total meal scenarios available 1149
No of scenarios eligible for revision 754
No of approved revisions by clinician 723 (96%)
No of declined revisions by clinician 31 (4%)
participants reported that using ABC4D software for insulin
bolus advice was more time consuming compared to their
conventional calculation.
B. Clinical Platform
Table II shows the use of the clinical revision software,
which has been used periodically during the six-week study to
revise the outcome of bolus recommendations. A total of 1149
bolus recommendations have been imported to the revision
platform of which 754 advice were eligible for revising the
outcome of the cases. Other bolus advice were ignored for
revision because of either missing glucose sensor data or
exclusion criteria of the adaptation metric (e.g. user has given
additional insulin or consumed a snack shortly after the advice
received). Out of all eligible imported bolus advice, 723 (96%)
proposed adaptations were approved by the physician and
uploaded to the patient platform. Only 4% of all proposed
adaptations have been declined manually by the clinician,
which was due to either human error (e.g. wrong value entered
by patient) or artefactual sensor data.
IV. DISCUSSION
Human factors are key components to ensure adherence
of patients and clinicians to information technologies for
therapeutic purposes. For maximum performance, a decision
support system for insulin dosing needs to be as user-friendly
as possible for both patients and clinicians. This is why end
users were involved from the beginning in the design and the
development phase of the proposed system. Results from a pi-
lot study over six weeks evaluating the usability of ABC4D are
encouraging where almost 90% of all bolus recommendations
have been followed by the participants.The difference in usage
of the patient platform between the first and last study week
has been highlighted in Table I. While participants used the log
book less at the end of the study phase to enter daily diabetes
related events (e.g. snacks, exercise or stress), the number of
insulin advice requests did not significantly change over the
study period. Further findings show, that the time needed to
request an insulin advice was significantly reduced in the last
week compared to the start of the study. As the software did
not provide a function to re-use previously entered manual
inputs (e.g. library of profiles), this reduction results from
the learning curve of the user to enter data more efficiently
when becoming more familiar with the software. However,
some participants still found the use of ABC4D more time
consuming compared to their conventional way of calculating
the insulin dose. To address this, future work could see the
system being integrated into a blood glucose meter or insulin
pump to reduce the number of manual user inputs. Also,
pre- and post-meal physical exercise could be measured using
existing commercial devices such as heart rate monitors or ac-
celerometers (e.g. Fitbit Inc, San Francisco, CA, USA). Safety,
as well as perceived safety, are other key aspects for adoption
of ABC4D. The proposed separation of the CBR cycle into a
patient platform for advice retrieval and a clinical platform for
supervision ensures patients that all changes of their insulin
therapy are approved by a clinical expert. After completion
of the study, 80 % participants stated that they trusted the
insulin advice which was generated by ABC4D (Table III).
A decision support system that would automatically adapts
insulin therapy without approval by a clinical expert might
receive less acceptance by patients. However, we show in our
pilot study that 96% of all proposed adaptations have been
approved by the clinical experts which indicates the potential
of further automation and reduced remote supervision. It is
important to note that the presented platform can hold various
algorithms for each of the CBR steps. While the ABC4D can
potentially hold other revision algorithms that do not rely on
CGM data (e.g. post-prandial capillary measurements [15]),
the algorithm implemented in the presented system utilises
retrospective CGM data to learn from previous case outcomes
and further adapt the bolus calculator parameters. However,
even without CGM, the patient platform is able to provide
real-time bolus advice. In this scenario, the revision and retain
steps will not be performed. For long-term usage, and once the
bolus calculator parameters have been optimised, CGM could
be used periodically (e.g. one month every four months) to
adapt to changes in the users environment. This is important
as CGM sensors are expensive and some users may not want
to continuously use CGM for longer periods. The overall
clinical performance of the system depends strongly on the
implemented algorithms to retrieve, reuse and adapt cases.
Further studies are on-going to assess the clinical efficacy of
ABC4D based on the presented architecture and the algorithm
proposed in [9] and [11].
V. CONCLUSION
Commercially available bolus calculators lack the ability to
automatically adapt over time and require frequent revisions.
We present the system architecture and initial usability results
of an advanced bolus calculator for diabetes (ABC4D) which
provides personalised and adaptive insulin recommendations.
ABC4D implements an in-silico validated algorithm based
on case-based reasoning (CBR), which differentiates between
various scenarios and adapts bolus calculator parameters ac-
cording to changes in the diet and life-style of the patient
by analysing the postprandial glucose excursion. In order
to ensure that only safe adaptations of the bolus calculator
parameters are performed, we propose to split the CBR cycle
into a patient platform and a clinical platform for supervision.
We show promising initial results of the presented system in
a pilot study assessing usability and acceptability, which are
key factors for the adoption of decision support systems for
insulin dosing.
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TABLE III
RESULTS OF THE ACCEPTABILITY/USABILITY QUESTIONNAIRE OF PATIENT PLATFORM (N=10)
Strongly Neither Agree Strongly
Agree Agree Nor Disagree Disagree Disagree
Acceptability Questions
I trusted the insulin dose advice generated by ABC4D. 2 6 0 2 0
The use of continuous glucose monitoring was acceptable. 4 6 0 0 0
Using ABC4D for insulin calculation caused more anxiety. 0 3 0 4 3
Overall, I would be happy to use ABC4D system for bolus calculation. 6 3 0 1 0
Usability Questions
The ABC4D main screen is clear and was easy to read. 5 5 0 0 0
Entering data on the screen was straightforward. 6 4 0 0 0
Using ABC4D for insulin calculations was time consuming. 3 2 1 3 1
I would consider the ABC4D app user-friendly. 5 5 0 0 0
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